The National Environment Agency has warned of a surge in cases of dengue in coming months. In fact, the number of cases reported so far this year is far exceeding those reported in 2018 and 2017!
With that in mind, how are biotech companies positioned to address this crisis at hand? And where can investors find attractive opportunities within this growing landscape? Michelle Martin invites Dr David Foster, CEO and Managing Director, Island Pharmaceuticals to find out more.

Money and Me: Expensive Mistakes When Market Shocks Hit
25:57

Market View: Why investors are questioning Oracle, the 200-year-old company powering ahead, and the EV maker in the black
21:11

Money and Me: Who Really Wins When Money Is Printed?
24:05